|
US7232899B2
(en)
|
1996-09-25 |
2007-06-19 |
The Scripps Research Institute |
Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use
|
|
AU4070499A
(en)
|
1998-04-30 |
1999-11-16 |
Cornell Research Foundation Inc. |
Adenoviral vectors with tandem fiber proteins
|
|
EP1112372A1
(en)
*
|
1998-09-11 |
2001-07-04 |
Genvec, Inc. |
Alternatively targeted adenovirus
|
|
EP1020529B1
(en)
*
|
1998-11-20 |
2005-06-01 |
Crucell Holland B.V. |
Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
|
|
IL133032A
(en)
*
|
1998-11-20 |
2007-06-03 |
Introgene Bv |
Adenoviral gene delivery vectors provided with a tissue tropism for smooth muscle cells and /or endothelial cells
|
|
JP2000279178A
(ja)
*
|
1999-02-24 |
2000-10-10 |
Japan Found Cancer Res |
ウイルスベクター
|
|
DE19932688B4
(de)
|
1999-07-13 |
2009-10-08 |
Scil Proteins Gmbh |
Design von Beta-Faltblatt-Proteinen des gamma-II-kristallins antikörperähnlichen
|
|
US7560527B1
(en)
|
1999-11-25 |
2009-07-14 |
Transgene S.A. |
Modified adenovirus fibre and uses
|
|
JP2003534805A
(ja)
*
|
2000-05-31 |
2003-11-25 |
ユニバーシティ オブ サスカチュワン |
変化した親和性を有する改変ウシアデノウイルス
|
|
JP2004512015A
(ja)
*
|
2000-06-02 |
2004-04-22 |
ノバルティス アクチエンゲゼルシャフト |
変異ファイバー蛋白質を有するアデノウィルス粒子
|
|
US20060228334A1
(en)
*
|
2002-07-10 |
2006-10-12 |
Manuel Rosa-Calatrava |
Modified adenoviral fiber with ablated to cellular receptors
|
|
US20060281090A1
(en)
*
|
2003-05-01 |
2006-12-14 |
University Of Washington Uw Tech Transfer- Invention Licensing |
Capsid-modified adenovirus vectors and methods of using the same
|
|
US7611868B2
(en)
*
|
2003-05-14 |
2009-11-03 |
Instituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Recombinant modified adenovirus fiber protein
|
|
DE10324447A1
(de)
|
2003-05-28 |
2004-12-30 |
Scil Proteins Gmbh |
Generierung künstlicher Bindungsproteine auf der Grundlage von Ubiquitin
|
|
GB0313132D0
(en)
*
|
2003-06-06 |
2003-07-09 |
Ich Productions Ltd |
Peptide ligands
|
|
US20070036721A1
(en)
*
|
2003-09-23 |
2007-02-15 |
Uab Resarch Foundation |
Methods and compositions for in vivo inflammation monitoring
|
|
ATE449105T1
(de)
*
|
2004-01-23 |
2009-12-15 |
Angeletti P Ist Richerche Bio |
Impfstoffträger für schimpansen-adenovirus
|
|
DE102004049479A1
(de)
|
2004-10-11 |
2006-04-13 |
Scil Proteins Gmbh |
Proteinkonjugate zur Verwendung in Therapie, Diagnose und Chromatographie
|
|
US20070010016A1
(en)
*
|
2005-03-11 |
2007-01-11 |
Mccelland Alan |
Gene transfer with adenoviruses having modified fiber proteins
|
|
WO2006133911A2
(en)
*
|
2005-06-17 |
2006-12-21 |
Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa |
Hepatitis c virus nucleic acid vaccine
|
|
WO2007094653A1
(en)
*
|
2006-02-13 |
2007-08-23 |
Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg |
Adenovirus particles having a chimeric adenovirus spike protein, use thereof and methods for producing such particles.
|
|
EP1925664A1
(en)
*
|
2006-11-15 |
2008-05-28 |
Scil proteins GmbH |
Artificial binding proteins based on a modified alpha helical region of ubiquitin
|
|
WO2009111738A2
(en)
|
2008-03-06 |
2009-09-11 |
Mayo Foundation For Medical Education And Research |
Single cycle replicating adenovirus vectors
|
|
AU2010332932B2
(en)
|
2009-12-14 |
2013-01-17 |
Navigo Proteins Gmbh |
Modified ubiquitin proteins having a specific binding activity for the extradomain B of fibronectin
|
|
JP6146821B2
(ja)
|
2011-06-15 |
2017-06-14 |
ナフィゴ プロテインズ ゲゼルシャフト ミット ベシュレンクテル ハフツングＮａｖｉｇｏ Ｐｒｏｔｅｉｎｓ ＧｍｂＨ |
修飾ユビキチンに基づく二量体型結合タンパク質
|
|
AU2014236207B2
(en)
|
2013-03-14 |
2019-05-23 |
Salk Institute For Biological Studies |
Oncolytic adenovirus compositions
|
|
KR20250081944A
(ko)
|
2014-09-24 |
2025-06-05 |
솔크 인스티튜트 포 바이올로지칼 스터디즈 |
종양 살상 바이러스 및 이의 사용방법
|
|
JP6738340B2
(ja)
|
2015-02-06 |
2020-08-12 |
ナフィゴ プロテインズ ゲゼルシャフト ミット ベシュレンクテル ハフツングＮａｖｉｇｏ Ｐｒｏｔｅｉｎｓ ＧｍｂＨ |
新規なｅｇｆｒ結合タンパク質
|
|
AU2016293063B2
(en)
|
2015-07-16 |
2018-11-08 |
Navigo Proteins Gmbh |
Novel immunoglobulin-binding proteins and their use in affinity purification
|
|
JP2018520675A
(ja)
|
2015-07-20 |
2018-08-02 |
ナフィゴ プロテインズ ゲゼルシャフト ミット ベシュレンクテル ハフツングＮａｖｉｇｏ Ｐｒｏｔｅｉｎｓ ＧｍｂＨ |
ジユビキチン変異タンパク質をベースとした新規結合タンパク質及びその生成方法
|
|
EP4155411A1
(en)
|
2016-02-23 |
2023-03-29 |
Salk Institute for Biological Studies |
Exogenous gene expression in therapeutic adenovirus for minimal impact on viral kinetics
|
|
WO2017147265A1
(en)
|
2016-02-23 |
2017-08-31 |
Salk Institute For Biological Studies |
High throughput assay for measuring adenovirus replication kinetics
|
|
EP3452097A1
(en)
|
2016-05-04 |
2019-03-13 |
Navigo Proteins GmbH |
Targeted compounds for the site-specific coupling of chemical moieties comprising a peptide linker
|
|
SG11201901066UA
(en)
|
2016-08-11 |
2019-03-28 |
Navigo Proteins Gmbh |
Novel alkaline stable immunoglobulin-binding proteins
|
|
CN110312799A
(zh)
|
2016-08-17 |
2019-10-08 |
博德研究所 |
新型crispr酶和系统
|
|
WO2018035388A1
(en)
|
2016-08-17 |
2018-02-22 |
The Broad Institute, Inc. |
Novel crispr enzymes and systems
|
|
EP3532082A4
(en)
|
2016-12-12 |
2020-08-26 |
Salk Institute for Biological Studies |
SYNTHETIC ADENOVIRUS TUMOR TARGETING AND THEIR USES
|
|
US12350368B2
(en)
|
2017-04-14 |
2025-07-08 |
The Broad Institute, Inc. |
Delivery of large payloads
|
|
US12227742B2
(en)
|
2017-10-23 |
2025-02-18 |
The Broad Institute, Inc. |
Nucleic acid modifiers
|
|
WO2019091918A1
(en)
|
2017-11-07 |
2019-05-16 |
Navigo Proteins Gmbh |
Fusion proteins with specificity for ed-b and long serum half-life for diagnosis or treatment of cancer
|
|
EP3710039A4
(en)
|
2017-11-13 |
2021-08-04 |
The Broad Institute, Inc. |
METHODS AND COMPOSITIONS FOR TREATMENT OF CANCER BY TARGETING THE CLEC2D-KLRB1 PATH
|
|
MX2020010499A
(es)
|
2018-04-09 |
2020-10-28 |
Salk Inst For Biological Studi |
Composiciones de adenovirus oncoliticas con propiedades aumentadas de replicacion.
|
|
CA3124110A1
(en)
|
2018-12-17 |
2020-06-25 |
The Broad Institute, Inc. |
Crispr-associated transposase systems and methods of use thereof
|
|
MA54501A
(fr)
|
2018-12-18 |
2021-10-27 |
Navigo Proteins Gmbh |
Nouvelles protéines de liaison spécifiques de folr1 pour le diagnostic et le traitement du cancer
|
|
WO2020236972A2
(en)
|
2019-05-20 |
2020-11-26 |
The Broad Institute, Inc. |
Non-class i multi-component nucleic acid targeting systems
|
|
US12297426B2
(en)
|
2019-10-01 |
2025-05-13 |
The Broad Institute, Inc. |
DNA damage response signature guided rational design of CRISPR-based systems and therapies
|
|
US11149286B1
(en)
|
2020-08-17 |
2021-10-19 |
Mayo Foundation For Medical Education And Research |
Adenovirus vectors and methods for using adenovirus vectors
|
|
CN119562762A
(zh)
|
2022-04-04 |
2025-03-04 |
加利福尼亚大学董事会 |
遗传互补组合物和方法
|
|
WO2025072383A1
(en)
|
2023-09-25 |
2025-04-03 |
The Broad Institute, Inc. |
Viral open reading frames, uses thereof, and methods of detecting the same
|
|
WO2025097055A2
(en)
|
2023-11-02 |
2025-05-08 |
The Broad Institute, Inc. |
Compositions and methods of use of t cells in immunotherapy
|
|
WO2025129158A1
(en)
|
2023-12-15 |
2025-06-19 |
The Broad Institute, Inc. |
Engineered arc delivery vesicles and uses thereof
|
|
WO2025250808A1
(en)
|
2024-05-29 |
2025-12-04 |
The Brigham And Women’S Hospital, Inc. |
Anti-crispr delivery compositions and methods
|